Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles

Background: Tuberculosis (TB) has been identified in skeletons over 6000 years old and still remains as the most prevalent infectious disease in the world; thus, there is a need for development of new drugs or tuning of old drugs. Nanotechnology, an advanced technology, plays a vital role in resear...

Full description

Bibliographic Details
Main Authors: Kalaiselvi Kumarasingam, Mangayarkarasi Vincent, Shivshankar R Mane, Raja Shunmugam, S Sivakumar, K R Uma Devi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:International Journal of Mycobacteriology
Subjects:
Isoniazid
norbornene
rifampicin
treatment
tuberculosis
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2018;volume=7;issue=1;spage=84;epage=88;aulast=Kumarasingam

Internet

http://www.ijmyco.org/article.asp?issn=2212-5531;year=2018;volume=7;issue=1;spage=84;epage=88;aulast=Kumarasingam

Similar Items